Novo Nordisk presents results from STRIDE study on Ozempic
Novo Nordisk (NVO) presented results from STRIDE, its phase 3b trial investigating the effects of once-weekly Ozempic injection 1 mg in adults ...
The Indian Express19h
Lancet study shows Ozempic can help people with diabetes walk better despite poor blood flow to limbs
The study, which was published in The Lancet, showed that 1 mg semaglutide helped adults with type 2 diabetes ... Meeting on March 29 and was funded by Novo Nordisk, the makers of Ozempic. The study ...